Glycothera is a specialized CDMO supporting biologics development across cell line development, process development, analytics, and GMP-aligned testing. Operating from integrated sites in Julich and Hanover, Germany, the company works within a unified scientific and quality framework that enables reliable, regulatory-ready CMC execution. With nearly three decades of development experience and long-standing contributions to biologics supported by EMA and FDA approvals, Glycothera partners with biotech and pharmaceutical companies to advance development programs with scientific depth, precision, and consistency.